APOL1 risk alleles are associated with exaggerated age-related changes in glomerular number and volume in African-American adults: An autopsy study

Journal of the American Society of Nephrology

Volumn 26, Issue 12, 2015, Pages 3179-3189

  Hoy, Wendy E ^a   Hughson, Michael D ^b   Kopp, Jeffrey B ^c   Mott, Susan A ^a   Bertram, John F ^d   Winkler, Cheryl A ^e  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^c NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^d MONASH UNIVERSITY   (Australia)

^e NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN; APOLIPOPROTEIN L1; DNA; UNCLASSIFIED DRUG; APOL1 PROTEIN, HUMAN; HIGH DENSITY LIPOPROTEIN;

ADULT; AFRICAN AMERICAN; AGE; AGED; ARTICLE; AUTOPSY; BODY MASS; CARDIOVASCULAR DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC RISK; GENOTYPE; GLOMERULUS; GLOMERULUS EPITHELIUM CELL; HUMAN; HUMAN TISSUE; HYPERTENSION; KIDNEY DISEASE; KIDNEY MASS; MALE; NEPHRON; PRIORITY JOURNAL; SEX DIFFERENCE; ADOLESCENT; AGING; ALLELE; ETHNOLOGY; GENETICS; MIDDLE AGED; ORGAN SIZE; PATHOLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; AFRICAN AMERICANS; AGE FACTORS; AGED; AGING; ALLELES; APOLIPOPROTEINS; BODY MASS INDEX; FEMALE; GENOTYPE; HUMANS; KIDNEY GLOMERULUS; LIPOPROTEINS, HDL; MALE; MIDDLE AGED; ORGAN SIZE; YOUNG ADULT;

EID: 84937983933     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2014080768     Document Type: Article

References (31)

1. GenoveseG, FriedmanDJ, RossMD, Lecordier L, Uzureau P, Freedman BI, Bowden DW, Langefeld CD, Oleksyk TK, Uscinski Knob AL, Bernhardy AJ, Hicks PJ, Nelson GW, Vanhollebeke B, Winkler CA, Kopp JB, Pays E, Pollak MR: Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science 329: 841-845, 2010
2. Lipkowitz MS, Freedman BI, Langefeld CD, Comeau ME, Bowden DW, Kao WH, Astor BC, Bottinger EP, Iyengar SK, Klotman PE, Freedman RG, Zhang W, Parekh RS, Choi MJ, Nelson GW, Winkler CA, Kopp JB; SK Investigators: Apolipoprotein L1 gene variants associate with hypertension-attributed nephropathy and the rate of kidney function decline in African Americans. Kidney Int 83: 114-120, 2013
3. Kopp JB, Nelson GW, Sampath K, Johnson RC, Genovese G, An P, Friedman D, Briggs W, Dart R, Korbet S, Mokrzycki MH, Kimmel PL, Limou S, Ahuja TS, Berns JS, Fryc J, Simon EE, SmithMC, Trachtman H, Michel DM, Schelling JR, Vlahov D, Pollak M, Winkler CA: APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy. J Am Soc Nephrol 22: 2129-2137, 2011
4. Ashley-Koch AE, Okocha EC, Garrett ME, Soldano K, De Castro LM, Jonassaint JC, Orringer EP, Eckman JR, Telen MJ: MYH9 and APOL1 are both associated with sickle cell disease nephropathy. Br J Haematol 155: 386-394, 2011
5. Foster MC, Coresh J, Fornage M, Astor BC, Grams M, Franceschini N, Boerwinkle E, Parekh RS, Kao WH: APOL1 variants associate with increased risk of CKD among African Americans. J Am Soc Nephrol 24: 1484-1491, 2013
6. Medapalli RK, He JC, Klotman PE: HIV-associated nephropathy: pathogenesis. Curr Opin Nephrol Hypertens 20: 306-311, 2011
7. Larsen CP, Beggs ML, Saeed M, Walker PD: Apolipoprotein L1 risk variants associate with systemic lupus erythematosus-associated collapsing glomerulopathy. J Am Soc Nephrol 24: 722-725, 2013
8. Freedman BI, Langefeld CD, Andringa KK, Croker JA, Williams AH, Garner NE, BirminghamDJ, Hebert LA, Hicks PJ, Segal MS, Edberg JC, Brown EE, Alarcón GS, Costenbader KH, Comeau ME, Criswell LA, Harley JB, James JA, Kamen DL, Lim SS, Merrill JT, Sivils KL, Niewold TB, Patel NM, Petri M, Ramsey-Goldman R, Reveille JD, Salmon JE, Tsao BP,Gibson KL, Byers JR, Vinnikova AK, Lea JP, Julian BA, Kimberly RP; Lupus Nephritis-End-Stage Renal Disease Consortium: End-stage renal disease in African Americans with lupus nephritis is associated with APOL1. Arthritis Rheum (Munch) 66: 390-396, 2014
9. Reeves-Daniel AM, DePalma JA, Bleyer AJ, Rocco MV, Murea M, Adams PL, Langefeld CD, Bowden DW, Hicks PJ, Stratta RJ, Lin JJ, Kiger DF, GautreauxMD, Divers J, Freedman BI: The APOL1 gene and allograft survival after kidney transplantation. Am J Transplant 11: 1025-1030, 2011
10. Parsa A, Kao WH, Xie D, Astor BC, Li M, Hsu CY, Feldman HI, Parekh RS, Kusek JW, Greene TH, Fink JC, Anderson AH, Choi MJ,Wright JT Jr, Lash JP, Freedman BI, Ojo A,Winkler CA, Raj DS, Kopp JB, He J, Jensvold NG, Tao K, Lipkowitz MS, Appel LJ; AASK Study InvestigatorsCRIC Study Investigators: APOL1 risk variants, race, and progression of chronic kidney disease. N Engl J Med 369: 2183-2196, 2013
11. Tzur S, Rosset S, Skorecki K, Wasser WG: APOL1 allelic variants are associated with lower age of dialysis initiation and thereby increased dialysis vintage in African and Hispanic Americans with non-diabetic end-stage kidney disease. Nephrol Dial Transplant 27: 1498-1505, 2012
12. Brenner BM, Garcia DL, Anderson S: Glomeruli and blood pressure. Less of one, more the other? Am J Hypertens 1: 335-347, 1988
13. Hoy WE, Bertram JF, Denton RD, Zimanyi M, Samuel T, Hughson MD: Nephron number, glomerular volume, renal disease and hypertension. Curr Opin Nephrol Hypertens 17: 258-265, 2008
14. Hughson MD, Gobe GC, Hoy WE, Manning RD Jr, Douglas-Denton R, Bertram JF: Associations of glomerular number and birth weight with clinicopathological features of African Americans and whites. Am J Kidney Dis 52: 18-28, 2008
15. Hughson MD, Puelles VG, Hoy WE, Douglas-Denton RN, Mott SA, Bertram JF. Hypertension, glomerular hypertrophy, and nephrosclerosis: the effect of race. Nephrol Dial Transpl 29: 1399-1409, 2014
16. Samuel T, Hoy WE, Douglas-Denton R, Hughson MD, Bertram JF: Determinants of glomerular volume in different cortical zones of the human kidney. J Am Soc Nephrol 16: 3102-3109, 2005
17. Hoy WE, Hughson MD, Diouf B, Zimanyi M, Samuel T, McNamara BJ, Douglas-Denton RN, Holden L, Mott SA, Bertram JF: Distribution of volumes of individual glomeruli in kidneys at autopsy: association with physical and clinical characteristics and with ethnic group. [Review]Am J Nephrol 33[Suppl 1]: 15-20, 2011
18. Zimanyi MA, Hoy WE, Douglas-Denton RN, Hughson MD, Holden LM, Bertram JF: Nephron number and individual glomerular volumes in male Caucasian and African American subjects. Nephrol Dial Transplant 24: 2428-2433, 2009
19. Hoy WE, Douglas-Denton RN, Hughson MD, Cass A, Johnson K, Bertram JF: A stereological study of glomerular number and volume: preliminary findings in a multiracial study of kidneys at autopsy. Kidney Int 63[Suppl 83]: S31-S37, 2003
20. McNamara BJ, Diouf B, Douglas-Denton RN, Hughson MD, Hoy WE, Bertram JF: A comparison of nephron number, glomerular volume and kidney weight in Senegalese Africans and African Americans. Nephrol Dial Transplant 25: 1514-1520, 2010
21. Friedman DJ, Pollak MR: Genetics of kidney failure and the evolving story of APOL1. J Clin Invest 121: 3367-3374, 2011
22. Larsen CP, Beggs ML, Saeed M, Ambruzs JM, Cossey LN, Messias NC, Walker PD, Freedman BI: Histopathologic findings associated with APOL1 risk variants in chronic kidney disease. Mod Pathol 28: 95-102, 2015
23. Lan X, Jhaveri A, Cheng K,Wen H, SaleemMA, Mathieson PW, Mikulak J, Aviram S, Malhotra A, Skorecki K, Singhal PC: APOL1 risk variants enhance podocyte necrosis through compromising lysosomal membrane permeability. Am J Physiol Renal Physiol 307: F326-F336, 2014
24. Hughson MD, Hoy WE, Douglas-Denton RN, Zimanyi MA, Bertram JF: Towards a definition of glomerulomegaly: clinical-pathological and methodological considerations. Nephrol Dial Transplant 26: 2202-2208, 2011
25. Puelles VG, Cullen-Mcewen LA, Taylor GE, Hughson MD, Hoy WE, Bertram JF: Associations between podocyte depletion, age, hypertension and nephron number in normal human kidneys [Abstract]. Nephrology (Carlton) 19(Supp S4): 1-104, 2014
26. Ito K, Bick AG, Flannick J, Friedman DJ, Genovese G, Parfenov MG, Depalma SR, Gupta N, Gabriel SB, Taylor HA Jr, Fox ER, Newton-Cheh C, Kathiresan S, Hirschhorn JN, Altshuler DM, Pollak MR, Wilson JG, Seidman JG, Seidman C: Increased burden of cardiovascular disease in carriers of APOL1 genetic variants. Circ Res 114: 845-850, 2014
27. Langefeld CD, Divers J, Pajewski NM, Hawfield AT, ReboussinDM, Bild DE, KaysenGA, Kimmel PL, Raj DS, Ricardo AC,Wright JT Jr, Sedor JR, Rocco MV, Freedman BI; Systolic Blood Pressure Intervention Trial (SPRINT): Apolipoprotein L1 gene variants associate with prevalent kidney but not prevalent cardiovascular disease in the Systolic Blood Pressure Intervention Trial. Kidney Int 87: 169-175, 2015
28. Bertram JF: Counting in the kidney. Kidney Int 59: 792-796, 2001
29. Cullen-McEwen LA, Bertram JF: Estimating total nephron number in the adult kidney using the physical disector/fractionator combination. In: Methods and Molecular Biology, edited by Michos O, New York, Humana Press, 2012, pp 109-119
30. Sterio DC: The unbiased estimation of number and sizes of arbitrary particles using the disector. J Microsc 134: 127-136, 1984
31. Atta MG, Estrella MM, Kuperman M, Foy MC, Fine DM, Racusen LC, LucasGM, NelsonGW,Warner AC, Winkler CA, Kopp JB: HIV-associated nephropathy patients with and without apolipoprotein L1 gene variants have similar clinical and pathological characteristics. Kidney Int 82: 338-343, 2012